nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CRABP1—liver cancer	0.494	0.855	CbGaD
Tretinoin—CYP1A1—liver cancer	0.084	0.145	CbGaD
Tretinoin—CYP3A7—Sorafenib—liver cancer	0.0249	0.167	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0249	0.167	CbGbCtD
Tretinoin—CYP2B6—Sorafenib—liver cancer	0.0237	0.159	CbGbCtD
Tretinoin—CYP3A5—Sorafenib—liver cancer	0.0187	0.126	CbGbCtD
Tretinoin—CYP2C8—Sorafenib—liver cancer	0.018	0.121	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—liver cancer	0.0144	0.0967	CbGbCtD
Tretinoin—CYP2C9—Sorafenib—liver cancer	0.0125	0.0842	CbGbCtD
Tretinoin—CYP3A4—Sorafenib—liver cancer	0.00729	0.049	CbGbCtD
Tretinoin—CYP3A4—Doxorubicin—liver cancer	0.00442	0.0297	CbGbCtD
Tretinoin—Alitretinoin—CRABP1—liver cancer	0.0031	0.818	CrCbGaD
Tretinoin—ALDH1A1—gall bladder—liver cancer	0.00168	0.129	CbGeAlD
Tretinoin—ALDH1A2—embryo—liver cancer	0.00146	0.112	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Epirubicin—liver cancer	0.00145	0.519	CbGdCrCtD
Tretinoin—CRABP1—embryo—liver cancer	0.00141	0.108	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—liver cancer	0.00134	0.481	CbGdCrCtD
Tretinoin—CRABP2—embryo—liver cancer	0.00128	0.0978	CbGeAlD
Tretinoin—ALDH1A1—embryo—liver cancer	0.00106	0.0815	CbGeAlD
Tretinoin—ALDH1A2—liver—liver cancer	0.000676	0.0519	CbGeAlD
Tretinoin—CYP4A11—liver—liver cancer	0.000652	0.05	CbGeAlD
Tretinoin—RXRA—liver—liver cancer	0.000587	0.045	CbGeAlD
Tretinoin—RARB—liver—liver cancer	0.000527	0.0405	CbGeAlD
Tretinoin—ALDH1A1—liver—liver cancer	0.000491	0.0377	CbGeAlD
Tretinoin—RXRB—liver—liver cancer	0.000485	0.0372	CbGeAlD
Tretinoin—CYP2C18—liver—liver cancer	0.000432	0.0331	CbGeAlD
Tretinoin—CYP3A7—liver—liver cancer	0.000411	0.0315	CbGeAlD
Tretinoin—RARA—liver—liver cancer	0.000404	0.031	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—liver cancer	0.000384	0.101	CrCbGaD
Tretinoin—CYP3A7-CYP3A51P—liver—liver cancer	0.000349	0.0268	CbGeAlD
Tretinoin—Acitretin—ALB—liver cancer	0.000306	0.0807	CrCbGaD
Tretinoin—CYP2A6—liver—liver cancer	0.000285	0.0219	CbGeAlD
Tretinoin—CYP2C8—liver—liver cancer	0.00016	0.0123	CbGeAlD
Tretinoin—CYP1A1—liver—liver cancer	0.000148	0.0113	CbGeAlD
Tretinoin—CYP3A5—liver—liver cancer	0.000145	0.0111	CbGeAlD
Tretinoin—CYP2B6—liver—liver cancer	0.000144	0.011	CbGeAlD
Tretinoin—CYP2C9—liver—liver cancer	0.000142	0.0109	CbGeAlD
Tretinoin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000135	0.00121	CcSEcCtD
Tretinoin—Hypersensitivity—Sorafenib—liver cancer	0.000135	0.00121	CcSEcCtD
Tretinoin—Renal impairment—Doxorubicin—liver cancer	0.000134	0.0012	CcSEcCtD
Tretinoin—Dermatitis bullous—Doxorubicin—liver cancer	0.000133	0.0012	CcSEcCtD
Tretinoin—Face oedema—Epirubicin—liver cancer	0.000133	0.00119	CcSEcCtD
Tretinoin—Asthenia—Sorafenib—liver cancer	0.000131	0.00118	CcSEcCtD
Tretinoin—Cardiac arrest—Epirubicin—liver cancer	0.000131	0.00118	CcSEcCtD
Tretinoin—Cardiac failure—Doxorubicin—liver cancer	0.00013	0.00117	CcSEcCtD
Tretinoin—Mood swings—Epirubicin—liver cancer	0.00013	0.00117	CcSEcCtD
Tretinoin—Cerebrovascular accident—Doxorubicin—liver cancer	0.00013	0.00117	CcSEcCtD
Tretinoin—Lethargy—Doxorubicin—liver cancer	0.00013	0.00117	CcSEcCtD
Tretinoin—Pruritus—Sorafenib—liver cancer	0.000129	0.00116	CcSEcCtD
Tretinoin—Blood creatinine increased—Epirubicin—liver cancer	0.000129	0.00116	CcSEcCtD
Tretinoin—Dehydration—Epirubicin—liver cancer	0.000128	0.00115	CcSEcCtD
Tretinoin—Pain in extremity—Doxorubicin—liver cancer	0.000127	0.00114	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000127	0.00114	CcSEcCtD
Tretinoin—Osteoarthritis—Doxorubicin—liver cancer	0.000127	0.00114	CcSEcCtD
Tretinoin—Dry skin—Epirubicin—liver cancer	0.000126	0.00113	CcSEcCtD
Tretinoin—Affect lability—Doxorubicin—liver cancer	0.000125	0.00113	CcSEcCtD
Tretinoin—Diarrhoea—Sorafenib—liver cancer	0.000125	0.00113	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000124	0.00111	CcSEcCtD
Tretinoin—Nasopharyngitis—Epirubicin—liver cancer	0.000123	0.00111	CcSEcCtD
Tretinoin—Face oedema—Doxorubicin—liver cancer	0.000123	0.00111	CcSEcCtD
Tretinoin—Gastritis—Epirubicin—liver cancer	0.000122	0.00109	CcSEcCtD
Tretinoin—Cardiac arrest—Doxorubicin—liver cancer	0.000121	0.00109	CcSEcCtD
Tretinoin—Dizziness—Sorafenib—liver cancer	0.000121	0.00109	CcSEcCtD
Tretinoin—Mood swings—Doxorubicin—liver cancer	0.000121	0.00108	CcSEcCtD
Tretinoin—Abdominal distension—Epirubicin—liver cancer	0.00012	0.00108	CcSEcCtD
Tretinoin—Blood creatinine increased—Doxorubicin—liver cancer	0.000119	0.00107	CcSEcCtD
Tretinoin—Asthma—Epirubicin—liver cancer	0.000119	0.00107	CcSEcCtD
Tretinoin—Dysphagia—Epirubicin—liver cancer	0.000119	0.00107	CcSEcCtD
Tretinoin—Dehydration—Doxorubicin—liver cancer	0.000118	0.00106	CcSEcCtD
Tretinoin—Dry skin—Doxorubicin—liver cancer	0.000117	0.00105	CcSEcCtD
Tretinoin—Pancreatitis—Epirubicin—liver cancer	0.000117	0.00105	CcSEcCtD
Tretinoin—Vomiting—Sorafenib—liver cancer	0.000116	0.00105	CcSEcCtD
Tretinoin—Rash—Sorafenib—liver cancer	0.000115	0.00104	CcSEcCtD
Tretinoin—Dermatitis—Sorafenib—liver cancer	0.000115	0.00104	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000115	0.00103	CcSEcCtD
Tretinoin—Headache—Sorafenib—liver cancer	0.000115	0.00103	CcSEcCtD
Tretinoin—Nasopharyngitis—Doxorubicin—liver cancer	0.000114	0.00102	CcSEcCtD
Tretinoin—Gastritis—Doxorubicin—liver cancer	0.000113	0.00101	CcSEcCtD
Tretinoin—Dysuria—Epirubicin—liver cancer	0.000111	0.001	CcSEcCtD
Tretinoin—Neutropenia—Epirubicin—liver cancer	0.000111	0.001	CcSEcCtD
Tretinoin—Abdominal distension—Doxorubicin—liver cancer	0.000111	0.000996	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000111	0.000994	CcSEcCtD
Tretinoin—Asthma—Doxorubicin—liver cancer	0.00011	0.000989	CcSEcCtD
Tretinoin—Dysphagia—Doxorubicin—liver cancer	0.00011	0.000989	CcSEcCtD
Tretinoin—Pollakiuria—Epirubicin—liver cancer	0.00011	0.000988	CcSEcCtD
Tretinoin—Nausea—Sorafenib—liver cancer	0.000109	0.000977	CcSEcCtD
Tretinoin—Photosensitivity reaction—Epirubicin—liver cancer	0.000109	0.000976	CcSEcCtD
Tretinoin—CYP3A4—liver—liver cancer	0.000109	0.00833	CbGeAlD
Tretinoin—Weight increased—Epirubicin—liver cancer	0.000108	0.000973	CcSEcCtD
Tretinoin—Pancreatitis—Doxorubicin—liver cancer	0.000108	0.00097	CcSEcCtD
Tretinoin—Weight decreased—Epirubicin—liver cancer	0.000108	0.000967	CcSEcCtD
Tretinoin—Pneumonia—Epirubicin—liver cancer	0.000107	0.000959	CcSEcCtD
Tretinoin—Infestation—Epirubicin—liver cancer	0.000106	0.000953	CcSEcCtD
Tretinoin—Drowsiness—Epirubicin—liver cancer	0.000106	0.000953	CcSEcCtD
Tretinoin—Infestation NOS—Epirubicin—liver cancer	0.000106	0.000953	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000105	0.000945	CcSEcCtD
Tretinoin—Renal failure—Epirubicin—liver cancer	0.000104	0.000937	CcSEcCtD
Tretinoin—Neuropathy peripheral—Epirubicin—liver cancer	0.000104	0.000935	CcSEcCtD
Tretinoin—Stomatitis—Epirubicin—liver cancer	0.000103	0.000929	CcSEcCtD
Tretinoin—Urinary tract infection—Epirubicin—liver cancer	0.000103	0.000927	CcSEcCtD
Tretinoin—Conjunctivitis—Epirubicin—liver cancer	0.000103	0.000927	CcSEcCtD
Tretinoin—Dysuria—Doxorubicin—liver cancer	0.000103	0.000925	CcSEcCtD
Tretinoin—Neutropenia—Doxorubicin—liver cancer	0.000103	0.000925	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000102	0.00092	CcSEcCtD
Tretinoin—Sweating—Epirubicin—liver cancer	0.000102	0.000914	CcSEcCtD
Tretinoin—Pollakiuria—Doxorubicin—liver cancer	0.000102	0.000914	CcSEcCtD
Tretinoin—Haematuria—Epirubicin—liver cancer	0.000101	0.000909	CcSEcCtD
Tretinoin—Photosensitivity reaction—Doxorubicin—liver cancer	0.0001	0.000903	CcSEcCtD
Tretinoin—Weight increased—Doxorubicin—liver cancer	0.0001	0.0009	CcSEcCtD
Tretinoin—Epistaxis—Epirubicin—liver cancer	0.0001	0.000899	CcSEcCtD
Tretinoin—Weight decreased—Doxorubicin—liver cancer	9.96e-05	0.000895	CcSEcCtD
Tretinoin—Sinusitis—Epirubicin—liver cancer	9.95e-05	0.000895	CcSEcCtD
Tretinoin—Agranulocytosis—Epirubicin—liver cancer	9.9e-05	0.00089	CcSEcCtD
Tretinoin—Pneumonia—Doxorubicin—liver cancer	9.87e-05	0.000887	CcSEcCtD
Tretinoin—Infestation—Doxorubicin—liver cancer	9.81e-05	0.000882	CcSEcCtD
Tretinoin—Infestation NOS—Doxorubicin—liver cancer	9.81e-05	0.000882	CcSEcCtD
Tretinoin—Drowsiness—Doxorubicin—liver cancer	9.81e-05	0.000882	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	9.73e-05	0.000875	CcSEcCtD
Tretinoin—Renal failure—Doxorubicin—liver cancer	9.64e-05	0.000867	CcSEcCtD
Tretinoin—Neuropathy peripheral—Doxorubicin—liver cancer	9.62e-05	0.000865	CcSEcCtD
Tretinoin—Haemoglobin—Epirubicin—liver cancer	9.57e-05	0.00086	CcSEcCtD
Tretinoin—Stomatitis—Doxorubicin—liver cancer	9.56e-05	0.00086	CcSEcCtD
Tretinoin—Conjunctivitis—Doxorubicin—liver cancer	9.54e-05	0.000858	CcSEcCtD
Tretinoin—Urinary tract infection—Doxorubicin—liver cancer	9.54e-05	0.000858	CcSEcCtD
Tretinoin—Hepatitis—Epirubicin—liver cancer	9.52e-05	0.000856	CcSEcCtD
Tretinoin—Haemorrhage—Epirubicin—liver cancer	9.52e-05	0.000856	CcSEcCtD
Tretinoin—Hypoaesthesia—Epirubicin—liver cancer	9.47e-05	0.000852	CcSEcCtD
Tretinoin—Pharyngitis—Epirubicin—liver cancer	9.45e-05	0.000849	CcSEcCtD
Tretinoin—Sweating—Doxorubicin—liver cancer	9.41e-05	0.000846	CcSEcCtD
Tretinoin—Urinary tract disorder—Epirubicin—liver cancer	9.4e-05	0.000845	CcSEcCtD
Tretinoin—Oedema peripheral—Epirubicin—liver cancer	9.38e-05	0.000843	CcSEcCtD
Tretinoin—Haematuria—Doxorubicin—liver cancer	9.35e-05	0.000841	CcSEcCtD
Tretinoin—Urethral disorder—Epirubicin—liver cancer	9.33e-05	0.000839	CcSEcCtD
Tretinoin—Epistaxis—Doxorubicin—liver cancer	9.25e-05	0.000832	CcSEcCtD
Tretinoin—Sinusitis—Doxorubicin—liver cancer	9.2e-05	0.000828	CcSEcCtD
Tretinoin—Visual impairment—Epirubicin—liver cancer	9.17e-05	0.000825	CcSEcCtD
Tretinoin—Agranulocytosis—Doxorubicin—liver cancer	9.16e-05	0.000823	CcSEcCtD
Tretinoin—Erythema multiforme—Epirubicin—liver cancer	9e-05	0.000809	CcSEcCtD
Tretinoin—Eye disorder—Epirubicin—liver cancer	8.9e-05	0.0008	CcSEcCtD
Tretinoin—Tinnitus—Epirubicin—liver cancer	8.88e-05	0.000798	CcSEcCtD
Tretinoin—Haemoglobin—Doxorubicin—liver cancer	8.85e-05	0.000796	CcSEcCtD
Tretinoin—Flushing—Epirubicin—liver cancer	8.83e-05	0.000794	CcSEcCtD
Tretinoin—Haemorrhage—Doxorubicin—liver cancer	8.81e-05	0.000792	CcSEcCtD
Tretinoin—Hepatitis—Doxorubicin—liver cancer	8.81e-05	0.000792	CcSEcCtD
Tretinoin—Hypoaesthesia—Doxorubicin—liver cancer	8.76e-05	0.000788	CcSEcCtD
Tretinoin—Pharyngitis—Doxorubicin—liver cancer	8.74e-05	0.000786	CcSEcCtD
Tretinoin—Urinary tract disorder—Doxorubicin—liver cancer	8.7e-05	0.000782	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—liver cancer	8.68e-05	0.00078	CcSEcCtD
Tretinoin—Angiopathy—Epirubicin—liver cancer	8.64e-05	0.000777	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—liver cancer	8.63e-05	0.000776	CcSEcCtD
Tretinoin—Chills—Epirubicin—liver cancer	8.54e-05	0.000768	CcSEcCtD
Tretinoin—Arrhythmia—Epirubicin—liver cancer	8.5e-05	0.000765	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—liver cancer	8.49e-05	0.000763	CcSEcCtD
Tretinoin—Alopecia—Epirubicin—liver cancer	8.41e-05	0.000756	CcSEcCtD
Tretinoin—Mental disorder—Epirubicin—liver cancer	8.34e-05	0.00075	CcSEcCtD
Tretinoin—Erythema multiforme—Doxorubicin—liver cancer	8.33e-05	0.000749	CcSEcCtD
Tretinoin—Malnutrition—Epirubicin—liver cancer	8.29e-05	0.000745	CcSEcCtD
Tretinoin—Erythema—Epirubicin—liver cancer	8.29e-05	0.000745	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—liver cancer	8.23e-05	0.00074	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—liver cancer	8.21e-05	0.000738	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—liver cancer	8.17e-05	0.000735	CcSEcCtD
Tretinoin—Flatulence—Epirubicin—liver cancer	8.17e-05	0.000734	CcSEcCtD
Tretinoin—Tension—Epirubicin—liver cancer	8.13e-05	0.000731	CcSEcCtD
Tretinoin—Nervousness—Epirubicin—liver cancer	8.05e-05	0.000724	CcSEcCtD
Tretinoin—Back pain—Epirubicin—liver cancer	8.02e-05	0.000721	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—liver cancer	7.99e-05	0.000719	CcSEcCtD
Tretinoin—Chills—Doxorubicin—liver cancer	7.9e-05	0.000711	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—liver cancer	7.87e-05	0.000707	CcSEcCtD
Tretinoin—Vision blurred—Epirubicin—liver cancer	7.81e-05	0.000702	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—liver cancer	7.78e-05	0.0007	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—liver cancer	7.72e-05	0.000694	CcSEcCtD
Tretinoin—Ill-defined disorder—Epirubicin—liver cancer	7.69e-05	0.000691	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—liver cancer	7.67e-05	0.000689	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—liver cancer	7.67e-05	0.000689	CcSEcCtD
Tretinoin—Anaemia—Epirubicin—liver cancer	7.66e-05	0.000689	CcSEcCtD
Tretinoin—Agitation—Epirubicin—liver cancer	7.62e-05	0.000685	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—liver cancer	7.56e-05	0.000679	CcSEcCtD
Tretinoin—Tension—Doxorubicin—liver cancer	7.52e-05	0.000677	CcSEcCtD
Tretinoin—Malaise—Epirubicin—liver cancer	7.47e-05	0.000672	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—liver cancer	7.45e-05	0.00067	CcSEcCtD
Tretinoin—Syncope—Epirubicin—liver cancer	7.43e-05	0.000668	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—liver cancer	7.42e-05	0.000667	CcSEcCtD
Tretinoin—Palpitations—Epirubicin—liver cancer	7.32e-05	0.000658	CcSEcCtD
Tretinoin—Loss of consciousness—Epirubicin—liver cancer	7.28e-05	0.000655	CcSEcCtD
Tretinoin—Cough—Epirubicin—liver cancer	7.23e-05	0.00065	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—liver cancer	7.23e-05	0.00065	CcSEcCtD
Tretinoin—Convulsion—Epirubicin—liver cancer	7.18e-05	0.000646	CcSEcCtD
Tretinoin—Hypertension—Epirubicin—liver cancer	7.15e-05	0.000643	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—liver cancer	7.11e-05	0.00064	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—liver cancer	7.09e-05	0.000637	CcSEcCtD
Tretinoin—Chest pain—Epirubicin—liver cancer	7.05e-05	0.000634	CcSEcCtD
Tretinoin—Arthralgia—Epirubicin—liver cancer	7.05e-05	0.000634	CcSEcCtD
Tretinoin—Myalgia—Epirubicin—liver cancer	7.05e-05	0.000634	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—liver cancer	7.05e-05	0.000634	CcSEcCtD
Tretinoin—Anxiety—Epirubicin—liver cancer	7.03e-05	0.000632	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	7.01e-05	0.00063	CcSEcCtD
Tretinoin—Discomfort—Epirubicin—liver cancer	6.97e-05	0.000627	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—liver cancer	6.91e-05	0.000622	CcSEcCtD
Tretinoin—Dry mouth—Epirubicin—liver cancer	6.9e-05	0.00062	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—liver cancer	6.88e-05	0.000618	CcSEcCtD
Tretinoin—Confusional state—Epirubicin—liver cancer	6.82e-05	0.000613	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—liver cancer	6.78e-05	0.000609	CcSEcCtD
Tretinoin—Anaphylactic shock—Epirubicin—liver cancer	6.76e-05	0.000608	CcSEcCtD
Tretinoin—Oedema—Epirubicin—liver cancer	6.76e-05	0.000608	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—liver cancer	6.74e-05	0.000606	CcSEcCtD
Tretinoin—Infection—Epirubicin—liver cancer	6.72e-05	0.000604	CcSEcCtD
Tretinoin—Cough—Doxorubicin—liver cancer	6.69e-05	0.000602	CcSEcCtD
Tretinoin—Shock—Epirubicin—liver cancer	6.65e-05	0.000598	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—liver cancer	6.64e-05	0.000597	CcSEcCtD
Tretinoin—Nervous system disorder—Epirubicin—liver cancer	6.63e-05	0.000596	CcSEcCtD
Tretinoin—Thrombocytopenia—Epirubicin—liver cancer	6.62e-05	0.000595	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—liver cancer	6.62e-05	0.000595	CcSEcCtD
Tretinoin—Tachycardia—Epirubicin—liver cancer	6.6e-05	0.000593	CcSEcCtD
Tretinoin—Skin disorder—Epirubicin—liver cancer	6.57e-05	0.000591	CcSEcCtD
Tretinoin—Hyperhidrosis—Epirubicin—liver cancer	6.54e-05	0.000588	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—liver cancer	6.53e-05	0.000587	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—liver cancer	6.53e-05	0.000587	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—liver cancer	6.53e-05	0.000587	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—liver cancer	6.51e-05	0.000585	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	6.48e-05	0.000583	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—liver cancer	6.45e-05	0.00058	CcSEcCtD
Tretinoin—Anorexia—Epirubicin—liver cancer	6.45e-05	0.00058	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—liver cancer	6.38e-05	0.000574	CcSEcCtD
Tretinoin—Hypotension—Epirubicin—liver cancer	6.32e-05	0.000568	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—liver cancer	6.31e-05	0.000567	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—liver cancer	6.26e-05	0.000563	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—liver cancer	6.26e-05	0.000563	CcSEcCtD
Tretinoin—Infection—Doxorubicin—liver cancer	6.22e-05	0.000559	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Epirubicin—liver cancer	6.16e-05	0.000554	CcSEcCtD
Tretinoin—Shock—Doxorubicin—liver cancer	6.16e-05	0.000554	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—liver cancer	6.14e-05	0.000552	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—liver cancer	6.13e-05	0.000551	CcSEcCtD
Tretinoin—Insomnia—Epirubicin—liver cancer	6.12e-05	0.00055	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—liver cancer	6.11e-05	0.000549	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—liver cancer	6.08e-05	0.000547	CcSEcCtD
Tretinoin—Paraesthesia—Epirubicin—liver cancer	6.07e-05	0.000546	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—liver cancer	6.05e-05	0.000544	CcSEcCtD
Tretinoin—Dyspnoea—Epirubicin—liver cancer	6.03e-05	0.000542	CcSEcCtD
Tretinoin—Somnolence—Epirubicin—liver cancer	6.01e-05	0.000541	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—liver cancer	5.96e-05	0.000536	CcSEcCtD
Tretinoin—Dyspepsia—Epirubicin—liver cancer	5.95e-05	0.000535	CcSEcCtD
Tretinoin—Decreased appetite—Epirubicin—liver cancer	5.88e-05	0.000529	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—liver cancer	5.85e-05	0.000526	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Epirubicin—liver cancer	5.84e-05	0.000525	CcSEcCtD
Tretinoin—Fatigue—Epirubicin—liver cancer	5.83e-05	0.000524	CcSEcCtD
Tretinoin—Pain—Epirubicin—liver cancer	5.78e-05	0.00052	CcSEcCtD
Tretinoin—Constipation—Epirubicin—liver cancer	5.78e-05	0.00052	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—liver cancer	5.7e-05	0.000513	CcSEcCtD
Tretinoin—Insomnia—Doxorubicin—liver cancer	5.66e-05	0.000509	CcSEcCtD
Tretinoin—Paraesthesia—Doxorubicin—liver cancer	5.62e-05	0.000505	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—liver cancer	5.58e-05	0.000502	CcSEcCtD
Tretinoin—Feeling abnormal—Epirubicin—liver cancer	5.57e-05	0.000501	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—liver cancer	5.56e-05	0.0005	CcSEcCtD
Tretinoin—Gastrointestinal pain—Epirubicin—liver cancer	5.53e-05	0.000497	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—liver cancer	5.51e-05	0.000495	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—liver cancer	5.44e-05	0.000489	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—liver cancer	5.4e-05	0.000486	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—liver cancer	5.39e-05	0.000485	CcSEcCtD
Tretinoin—Urticaria—Epirubicin—liver cancer	5.37e-05	0.000483	CcSEcCtD
Tretinoin—Pain—Doxorubicin—liver cancer	5.35e-05	0.000481	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—liver cancer	5.35e-05	0.000481	CcSEcCtD
Tretinoin—Abdominal pain—Epirubicin—liver cancer	5.35e-05	0.000481	CcSEcCtD
Tretinoin—Body temperature increased—Epirubicin—liver cancer	5.35e-05	0.000481	CcSEcCtD
Tretinoin—Feeling abnormal—Doxorubicin—liver cancer	5.16e-05	0.000464	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—liver cancer	5.12e-05	0.00046	CcSEcCtD
Tretinoin—Hypersensitivity—Epirubicin—liver cancer	4.98e-05	0.000448	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—liver cancer	4.97e-05	0.000447	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—liver cancer	4.95e-05	0.000445	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—liver cancer	4.95e-05	0.000445	CcSEcCtD
Tretinoin—Asthenia—Epirubicin—liver cancer	4.85e-05	0.000436	CcSEcCtD
Tretinoin—Pruritus—Epirubicin—liver cancer	4.78e-05	0.00043	CcSEcCtD
Tretinoin—Diarrhoea—Epirubicin—liver cancer	4.63e-05	0.000416	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—liver cancer	4.61e-05	0.000415	CcSEcCtD
Tretinoin—Asthenia—Doxorubicin—liver cancer	4.49e-05	0.000404	CcSEcCtD
Tretinoin—Dizziness—Epirubicin—liver cancer	4.47e-05	0.000402	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—liver cancer	4.43e-05	0.000398	CcSEcCtD
Tretinoin—Vomiting—Epirubicin—liver cancer	4.3e-05	0.000387	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—liver cancer	4.28e-05	0.000385	CcSEcCtD
Tretinoin—Rash—Epirubicin—liver cancer	4.26e-05	0.000383	CcSEcCtD
Tretinoin—Dermatitis—Epirubicin—liver cancer	4.26e-05	0.000383	CcSEcCtD
Tretinoin—Headache—Epirubicin—liver cancer	4.24e-05	0.000381	CcSEcCtD
Tretinoin—Dizziness—Doxorubicin—liver cancer	4.14e-05	0.000372	CcSEcCtD
Tretinoin—Nausea—Epirubicin—liver cancer	4.02e-05	0.000361	CcSEcCtD
Tretinoin—Vomiting—Doxorubicin—liver cancer	3.98e-05	0.000358	CcSEcCtD
Tretinoin—Rash—Doxorubicin—liver cancer	3.95e-05	0.000355	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—liver cancer	3.94e-05	0.000354	CcSEcCtD
Tretinoin—Headache—Doxorubicin—liver cancer	3.92e-05	0.000352	CcSEcCtD
Tretinoin—Nausea—Doxorubicin—liver cancer	3.72e-05	0.000334	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—EPT1—liver cancer	5.5e-06	3.87e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—liver cancer	5.49e-06	3.86e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARA—liver cancer	5.48e-06	3.85e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—liver cancer	5.44e-06	3.83e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A1—liver cancer	5.44e-06	3.82e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GOT2—liver cancer	5.41e-06	3.8e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTA1—liver cancer	5.39e-06	3.79e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CPT1B—liver cancer	5.38e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GLUL—liver cancer	5.38e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CG—liver cancer	5.37e-06	3.77e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—liver cancer	5.37e-06	3.77e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—liver cancer	5.37e-06	3.77e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—liver cancer	5.37e-06	3.77e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NAT2—liver cancer	5.33e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CRABP1—liver cancer	5.31e-06	3.74e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—liver cancer	5.29e-06	3.72e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TAT—liver cancer	5.22e-06	3.67e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYCS—liver cancer	5.19e-06	3.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NR1H4—liver cancer	5.19e-06	3.65e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—liver cancer	5.18e-06	3.64e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.12e-06	3.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALDOB—liver cancer	5.11e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTA3—liver cancer	5.1e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GOT1—liver cancer	5.09e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GGT1—liver cancer	5.09e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP2E1—liver cancer	5.08e-06	3.57e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—MTHFR—liver cancer	5.07e-06	3.56e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HPGDS—liver cancer	5.03e-06	3.54e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARA—liver cancer	4.97e-06	3.5e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HPGDS—liver cancer	4.92e-06	3.46e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CRABP1—liver cancer	4.87e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.78e-06	3.36e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SERPINE1—liver cancer	4.76e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYCS—liver cancer	4.76e-06	3.34e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CD—liver cancer	4.72e-06	3.32e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CG—liver cancer	4.69e-06	3.3e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GGT1—liver cancer	4.67e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GOT1—liver cancer	4.67e-06	3.28e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—liver cancer	4.66e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTA4—liver cancer	4.66e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—liver cancer	4.66e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HPGDS—liver cancer	4.64e-06	3.26e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—liver cancer	4.63e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.62e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTP1—liver cancer	4.57e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.56e-06	3.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTA2—liver cancer	4.54e-06	3.19e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—liver cancer	4.53e-06	3.18e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HMOX1—liver cancer	4.51e-06	3.17e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PSMD10—liver cancer	4.48e-06	3.15e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PSMA4—liver cancer	4.48e-06	3.15e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.47e-06	3.14e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—liver cancer	4.43e-06	3.11e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.39e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTA1—liver cancer	4.38e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PSMD10—liver cancer	4.38e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PSMA4—liver cancer	4.38e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GOT2—liver cancer	4.36e-06	3.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAT2—liver cancer	4.34e-06	3.05e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—liver cancer	4.27e-06	3e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GOT2—liver cancer	4.26e-06	3e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—liver cancer	4.26e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HPGDS—liver cancer	4.26e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.23e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.21e-06	2.96e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—liver cancer	4.2e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—liver cancer	4.19e-06	2.95e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—liver cancer	4.18e-06	2.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.17e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDOB—liver cancer	4.16e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.15e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PSMD10—liver cancer	4.14e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PSMA4—liver cancer	4.14e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HMOX1—liver cancer	4.13e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CD—liver cancer	4.13e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CB—liver cancer	4.11e-06	2.89e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—liver cancer	4.11e-06	2.89e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2E1—liver cancer	4.1e-06	2.88e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—liver cancer	4.09e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—liver cancer	4.07e-06	2.86e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GOT2—liver cancer	4.03e-06	2.83e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—liver cancer	4.01e-06	2.82e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—liver cancer	4.01e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2E1—liver cancer	4.01e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—liver cancer	3.98e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CRABP1—liver cancer	3.97e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.86e-06	2.71e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—liver cancer	3.85e-06	2.71e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYCS—liver cancer	3.84e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.81e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PSMD10—liver cancer	3.8e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PSMA4—liver cancer	3.8e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2E1—liver cancer	3.79e-06	2.66e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GOT1—liver cancer	3.76e-06	2.65e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GGT1—liver cancer	3.76e-06	2.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYCS—liver cancer	3.75e-06	2.64e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CD—liver cancer	3.74e-06	2.63e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MTHFR—liver cancer	3.71e-06	2.61e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—liver cancer	3.7e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GOT2—liver cancer	3.69e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GGT1—liver cancer	3.68e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GOT1—liver cancer	3.68e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.67e-06	2.58e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—liver cancer	3.65e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARA—liver cancer	3.64e-06	2.56e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CB—liver cancer	3.6e-06	2.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.57e-06	2.51e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CPT1B—liver cancer	3.55e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GLUL—liver cancer	3.55e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYCS—liver cancer	3.54e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GOT1—liver cancer	3.48e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GGT1—liver cancer	3.48e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2E1—liver cancer	3.47e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HPGDS—liver cancer	3.47e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.45e-06	2.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NR1H4—liver cancer	3.42e-06	2.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—liver cancer	3.4e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—liver cancer	3.38e-06	2.38e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA3—liver cancer	3.36e-06	2.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.36e-06	2.36e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARA—liver cancer	3.34e-06	2.35e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—liver cancer	3.34e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—liver cancer	3.31e-06	2.32e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—liver cancer	3.26e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—liver cancer	3.26e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYCS—liver cancer	3.25e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GGT1—liver cancer	3.19e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GOT1—liver cancer	3.19e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.14e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—liver cancer	3.12e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—liver cancer	3.12e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—liver cancer	3.11e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.1e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSMD10—liver cancer	3.09e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSMA4—liver cancer	3.09e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—liver cancer	3.08e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA4—liver cancer	3.08e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—liver cancer	3.04e-06	2.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—liver cancer	3.01e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—liver cancer	3.01e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GOT2—liver cancer	3.01e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA2—liver cancer	3e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—liver cancer	2.95e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA1—liver cancer	2.89e-06	2.03e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—liver cancer	2.88e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—liver cancer	2.87e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—liver cancer	2.86e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—liver cancer	2.86e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAT2—liver cancer	2.86e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2E1—liver cancer	2.83e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—liver cancer	2.82e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—liver cancer	2.76e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—liver cancer	2.75e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—liver cancer	2.74e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDOB—liver cancer	2.74e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.74e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—liver cancer	2.71e-06	1.9e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARA—liver cancer	2.69e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—liver cancer	2.68e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYCS—liver cancer	2.64e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARA—liver cancer	2.63e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—liver cancer	2.63e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CRABP1—liver cancer	2.62e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GGT1—liver cancer	2.59e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GOT1—liver cancer	2.59e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—liver cancer	2.54e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—liver cancer	2.51e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—liver cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—liver cancer	2.49e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARA—liver cancer	2.49e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—liver cancer	2.48e-06	1.74e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—liver cancer	2.39e-06	1.68e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—liver cancer	2.33e-06	1.64e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—liver cancer	2.33e-06	1.63e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—liver cancer	2.31e-06	1.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—liver cancer	2.3e-06	1.62e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HPGDS—liver cancer	2.29e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARA—liver cancer	2.28e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—liver cancer	2.26e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.23e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—liver cancer	2.23e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—liver cancer	2.19e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—liver cancer	2.19e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—liver cancer	2.18e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—liver cancer	2.14e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—liver cancer	2.13e-06	1.5e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—liver cancer	2.09e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—liver cancer	2.06e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.05e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—liver cancer	2.05e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSMA4—liver cancer	2.04e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSMD10—liver cancer	2.04e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—liver cancer	2.03e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—liver cancer	2.03e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—liver cancer	2e-06	1.41e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—liver cancer	1.99e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—liver cancer	1.98e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GOT2—liver cancer	1.98e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—liver cancer	1.96e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—liver cancer	1.95e-06	1.37e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—liver cancer	1.89e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—liver cancer	1.89e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—liver cancer	1.87e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.86e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARA—liver cancer	1.86e-06	1.3e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—liver cancer	1.85e-06	1.3e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—liver cancer	1.79e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—liver cancer	1.77e-06	1.24e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYCS—liver cancer	1.74e-06	1.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—liver cancer	1.73e-06	1.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—liver cancer	1.72e-06	1.21e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GGT1—liver cancer	1.71e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GOT1—liver cancer	1.71e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—liver cancer	1.7e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.67e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—liver cancer	1.63e-06	1.15e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—liver cancer	1.63e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—liver cancer	1.59e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—liver cancer	1.54e-06	1.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—liver cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—liver cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—liver cancer	1.5e-06	1.05e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—liver cancer	1.46e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—liver cancer	1.41e-06	9.93e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—liver cancer	1.4e-06	9.82e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—liver cancer	1.38e-06	9.7e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—liver cancer	1.34e-06	9.41e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—liver cancer	1.34e-06	9.39e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—liver cancer	1.25e-06	8.77e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARA—liver cancer	1.22e-06	8.61e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—liver cancer	1.22e-06	8.56e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—liver cancer	1.19e-06	8.37e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—liver cancer	1.09e-06	7.67e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—liver cancer	1.08e-06	7.58e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—liver cancer	1.05e-06	7.4e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—liver cancer	1.05e-06	7.37e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—liver cancer	1.01e-06	7.11e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—liver cancer	9.95e-07	7e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—liver cancer	9.22e-07	6.48e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—liver cancer	9.13e-07	6.41e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—liver cancer	9.1e-07	6.4e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—liver cancer	8.81e-07	6.19e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—liver cancer	8.61e-07	6.05e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—liver cancer	8.13e-07	5.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—liver cancer	8.03e-07	5.65e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—liver cancer	7.45e-07	5.24e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—liver cancer	7.43e-07	5.22e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—liver cancer	6.07e-07	4.26e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—liver cancer	4.9e-07	3.44e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—liver cancer	4e-07	2.81e-06	CbGpPWpGaD
